Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-10-13 13:21:16
- Reporting Period:
- 2009-10-09
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 858803 | Avanir Pharmaceuticals Inc. | AVNR | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033508 | Alain Schreiber Jay Moorin | C/O Proquest Investments C/O Proquest In 90 Nassau Street, 5Th Floor 90 Nassau St Princeton Princeton NJ 08542-4520 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2009-10-12 | 427,145 | $2.12 | 7,672,889 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Billionaire Hedge Funds
